Responsibility of the doctor who prescribes serotonin and noradrenaline reuptake inhibitor (SNRI) for patients with chronic musculoskeletal pain

Abstract
One of the serotonin and noradrenaline reuptake inhibitors (SNRIs), duloxetine, is indicated for the management of chronic musculoskeletal pain as it helps inhibit pain signals by activating descending pain inhibitory pathways.1

Source: Psychiatry and Clinical Neurosciences - October 24, 2017 Category: Neuroscience Authors: Takahiko Nagamine Tags: Letter to the Editor Source Type: research